Clinical Trial

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-BCMA/CD70 CAR-T cells in the treatment of patients with Multi-drug resistant SRNS
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-12; most recent amendment 2025-08-28.
Trial Details
NCT Number NCT06553898
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Conditions Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy
Enrollment 18 participants
Start Date 2024-08-13
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-29